SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 23rd, 2024 • Rani Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 22, 2024, between Rani Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SERIES B COMMON STOCK PURCHASE WARRANT RANI THERAPEUTICS HOLDINGS, INC.Warrant Agreement • July 23rd, 2024 • Rani Therapeutics Holdings, Inc. • Pharmaceutical preparations
THIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 23, 2025 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on January 23, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rani Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
